Hi,
The company has already told us the trials are progressing well.
Why not , no adverse effect 67% Orr for people that have already failed Checkpoint .
What's not to like if you in that position.
I would imagine the Keynote will be last of the results released.
Aloha
- Forums
- ASX - By Stock
- VLA
- Gilead buys Kite Pharma for $11.9 BN
Gilead buys Kite Pharma for $11.9 BN, page-19
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)